Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Zypadhera (olanzapine) Important Safety Information from Lilly following approval by the IMB

19 January 2009

Please find hereunder the safety information communication from Lilly on the association of Zypadhera (olanzapine powder and solvent for prolonged release suspension for injection) and post injection syndrome.

Zypadhera (olanzapine) - Important Safety Information





Date Printed: 24 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971